Geron Corporation (GERN)
NASDAQ: GERN
· Real-Time Price · USD
1.35
-0.03 (-2.17%)
At close: Oct 03, 2025, 3:59 PM
1.35
-0.01%
After-hours: Oct 03, 2025, 04:41 PM EDT
Geron Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|
| Government Rebates Revenue | -459K | -66K | n/a | -364K | -11K |
| Government Rebates Revenue Growth | +595.45% | n/a | -100.00% | +3209.09% | n/a |
| Product Revenue | 49.01M | 39.44M | 48.29M | 28.21M | 780K |
| Product Revenue Growth | +24.27% | -18.33% | +71.17% | +3516.54% | n/a |
| Revenues Before Adjustments Revenue | 57.87M | 45.31M | 56.76M | 32.66M | 890K |
| Revenues Before Adjustments Revenue Growth | +27.72% | -20.17% | +73.81% | +3569.33% | n/a |
| Sales Returns And Allowance Revenue | -518K | -113K | n/a | -82K | -2K |
| Sales Returns And Allowance Revenue Growth | +358.41% | n/a | -100.00% | +4000.00% | n/a |
| Total Gross To Net Adjustments Revenue | -8.87M | -5.88M | n/a | -4.45M | -110K |
| Total Gross To Net Adjustments Revenue Growth | +50.90% | n/a | -100.00% | +3943.64% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 38.56M | 40.02M | 43.37M | 35.88M | 38.99M | 26.79M | 21.16M | 18.35M | 16.49M | 12.89M | 13.84M | 15.64M | 7.44M | 6.7M | 7.87M | 7.26M | 7.06M | 7.48M | 7.09M | 6.51M | 5.96M | 6.12M | 5.26M | 4.99M | 5.19M | 5.45M | 4.88M | 4.26M | 4.25M | 5.32M | 5.45M | 4.77M | 4.41M | 4.66M | 4.75M | 4.67M | 4.55M | 4.79M | 4.88M | 4.33M | 3.98M | 4.6M |
| Selling, General, and Administrative Revenue Growth | -3.65% | -7.72% | +20.89% | -7.98% | +45.54% | +26.61% | +15.31% | +11.28% | +27.89% | -6.86% | -11.49% | +110.16% | +11.11% | -14.90% | +8.49% | +2.79% | -5.60% | +5.50% | +8.88% | +9.23% | -2.61% | +16.44% | +5.25% | -3.80% | -4.79% | +11.65% | +14.54% | +0.40% | -20.11% | -2.55% | +14.34% | +8.26% | -5.39% | -2.06% | +1.91% | +2.62% | -5.13% | -1.82% | +12.64% | +8.98% | -13.54% | n/a |
| Research and Development Revenue | 21.74M | 15.08M | 23.43M | 20.15M | 30.78M | 29.37M | 32.91M | 29.43M | 35.49M | 27.22M | 28.21M | 24.6M | 20.61M | 22.1M | 24.15M | 18.53M | 21.94M | 21.11M | 16.23M | 13.61M | 10.85M | 10.8M | 24.92M | 11.11M | 10.13M | 5.91M | 5.08M | 2.71M | 3.2M | 2.44M | 2.52M | 2.64M | 2.5M | 3.37M | 4.12M | 4.32M | 4.58M | 5.03M | 3.98M | 4.05M | 4.81M | 4.99M |
| Research and Development Revenue Growth | +44.16% | -35.65% | +16.28% | -34.52% | +4.79% | -10.75% | +11.84% | -17.09% | +30.39% | -3.51% | +14.66% | +19.40% | -6.76% | -8.49% | +30.35% | -15.54% | +3.90% | +30.10% | +19.21% | +25.52% | +0.40% | -56.66% | +124.35% | +9.62% | +71.59% | +16.24% | +87.70% | -15.51% | +31.31% | -3.29% | -4.32% | +5.52% | -25.93% | -18.11% | -4.61% | -5.60% | -9.10% | +26.39% | -1.68% | -15.84% | -3.51% | n/a |